Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan

BMJ Open. 2018 May 20;8(5):e021898. doi: 10.1136/bmjopen-2018-021898.

Abstract

Objective: To assess virus-specific hospitalisation rates, risk factors for illness severity and seasonal trends in children hospitalised with acute respiratory infections (ARI).

Design: Prospective cohort study.

Setting: A government hospital serving low-income and middle-income population in Amman, Jordan.

Participants: Children under 2 years of age hospitalised with fever and/or respiratory symptoms (n=3168) from 16 March 2010 to 31 March 2013. Children with chemotherapy-associated neutropenia and newborns who had never been discharged after birth were excluded from the study.

Outcome measures: Hospitalisation rates and markers of illness severity: admission to intensive care unit (ICU), mechanical ventilation (MV), oxygen therapy, length of stay (LOS) and death.

Results: Of the 3168 subjects, 2581 (82%) had at least one respiratory virus detected, with respiratory syncytial virus (RSV) being the most predominant pathogen isolated. During admission, 1013 (32%) received oxygen therapy, 284 (9%) were admitted to ICU, 111 (4%) were placed on MV and 31 (1%) children died. Oxygen therapy was higher in RSV-only subjects compared with human rhinovirus-only (42%vs29%, p<0.001), adenovirus-only (42%vs21%, p<0.001) and human parainfluenza virus-only (42%vs23%, p<0.001) subjects. The presence of an underlying medical condition was associated with oxygen therapy (adjusted OR (aOR) 1.95, 95% CI 1.49 to 2.56), ICU admission (aOR 2.51, 95% CI 1.71 to 3.68), MV (aOR 1.91, 95% CI 1.11 to 3.28) and longer LOS (aOR1.71, 95% CI 1.37 to 2.13). Similarly, younger age was associated with oxygen therapy (0.23, 95% CI 0.17 to 0.31), ICU admission (aOR 0.47, 95% CI 0.30 to 0.74), MV (0.28, 95% CI 0.15 to 0.53) and longer LOS (aOR 0.47, 95% CI 0.38 to 0.59). Pneumonia was strongly associated with longer LOS (aOR 2.07, 95% CI 1.65 to 2.60), oxygen therapy (aOR 2.94, 95% CI 2.22 to 3.89), ICU admission (aOR 3.12, 95% CI 2.16 to 4.50) and MV (aOR 3.33, 95% CI 1.85 to 6.00). Virus-specific hospitalisation rates ranged from 0.5 to 10.5 per 1000 children.

Conclusion: Respiratory viruses are associated with severe illness in Jordanian children hospitalised with ARI. Prevention strategies such as extended breast feeding, increased access to palivizumab and RSV vaccine development could help decrease hospitalisation rates and illness severity, particularly in young children with underlying medical conditions.

Keywords: community child health; infectious diseases; respiratory infections.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoviridae
  • Antiviral Agents / therapeutic use
  • Female
  • Humans
  • Infant
  • Intensive Care Units
  • Jordan / epidemiology
  • Length of Stay / statistics & numerical data*
  • Male
  • Oxygen Inhalation Therapy
  • Palivizumab / therapeutic use
  • Parainfluenza Virus 1, Human
  • Prospective Studies
  • Respiratory Syncytial Virus Infections / epidemiology*
  • Respiratory Syncytial Virus Infections / prevention & control
  • Respiratory Syncytial Virus Vaccines / therapeutic use*
  • Respiratory Syncytial Virus, Human / isolation & purification
  • Respiratory Tract Infections / epidemiology
  • Respiratory Tract Infections / prevention & control
  • Respiratory Tract Infections / virology*
  • Rhinovirus
  • Risk Factors

Substances

  • Antiviral Agents
  • Respiratory Syncytial Virus Vaccines
  • Palivizumab